Search terms
Results 1 - 10 of 101 - ordered by :
Pages: 1 2 3 4 5 6 7 ... 11

EuroIntervention Five-year clinical outcomes in a real-world population of patients with long coronary lesions treated with the 38mm cobalt-chromium everolimus-eluting stent The majority of patients ...

Date : 06/05/2016 Item size : 32120 bytes

Lemos P., Chandwani P., Saxena S., Ramachandran P., Abhyankar A., Campos C., Marchini J., Galon M., Verma P., Sandhu M., Parikh N., Bhupali A., Jain S., Prajapati J. AIMS The aim of this registry was ...

Date : 06/05/2016 Item size : 31679 bytes

Van Der Heijden L., Von Birgelen C., Kok M., Danse P., Jessurun G., Hautvast R., Löwik M., Tjon Joe Gin R., Schramm A., Louwerenburg J., Hartmann M., Linssen G., Doggen C., Stoel M. AIMS ...

Date : 06/05/2016 Item size : 32038 bytes

May A., Carlyle A., Robaei D., Pitney M., Ooi S., Giles R., Jepson N. AIMS The key concern in using bioresorbable vascular scaffolds (BVS) in CTO is the duration of clinical and safety ...

Date : 06/05/2016 Item size : 31268 bytes

Moreno R., Steinwender C., Dirkali A., Polad J., Fajadet J., Musumeci G., Eber B., Christen T., Dawkins K. AIMS The objective of the PROMUS Element™ European Post-Approval (PE-Prove) Registry is to ...

Date : 06/05/2016 Item size : 32537 bytes

AIMS Comparison of performance of Ultimaster sirolimus eluting stent with bioresorbable polymer (BP-SES) with the Xience everolimus eluting stent featuring permanent polymer coating (PP-EES), was ...

Date : 06/05/2016 Item size : 32250 bytes

METHODS AND RESULTS Consecutive 6266 non-emergent PCI patients with aspirin and clopidogrel therapy were enrolled prospectively in the single-center, large-volume investigation from January to ...

Date : 06/05/2016 Item size : 31757 bytes

Lemmert M., Van Domburg R., Van Mieghem N., Diletti R., Regar E., Zijlstra F., Van Geuns R., De Jaegere P., Boersma E., Daemen J. AIMS To compare the safety and efficacy of a third-generation ...

Date : 06/05/2016 Item size : 31917 bytes

The long-term (mean follow-up duration 58.0±38.4 months) MACE-free survival rate in the DES group did not differ significantly from the CABG group (86.6% vs. 81.4%, log-rank p=0.72). Of interest, ...

Date : 06/05/2016 Item size : 32271 bytes

Kherad B., Haverkamp W., Tschöpe C., Krackhardt F. AIMS Comparisons between conventional and drug-eluting balloon strategies for treatment of the side branch in UPLM coronary bifurcation disease are ...

Date : 06/05/2016 Item size : 32530 bytes